R-mini-CHOP

DRUG2 trials

Sponsors

Nordic Lymphoma Group, AstraZeneca

Conditions

DLBCLDiffuse Large B Cell LymphomaLarge B-cell Lymphoma

Phase 3

A Randomized, Multicenter, Phase III Trial Comparing Treatment With R-mini-CHOP With R-mini-CHP + Polatuzumab Vedotin in Patients With Diffuse Large Cell B Cell Lymphoma

RecruitingNCT04332822

Nordic Lymphoma GroupDiffuse Large B Cell Lymphoma, DLBCL

Start: 2020-08-19End: 2028-12-28Target: 300Updated: 2024-09-19

AZD0486 1L Therapy for Elderly or Unfit Participants With LBCL

RecruitingNCT07215585

AstraZenecaLarge B-cell Lymphoma

Start: 2025-11-11End: 2033-07-28Target: 420Updated: 2026-03-20

Related Papers

Subgroup analysis of older patients ≥60 years with diffuse large B-cell lymphoma in the phase 3 POLARIX study

Blood Advances2025-03-145 citations

S227: INITIAL SAFETY DATA FROM THE PHASE 3 POLAR BEAR TRIAL IN ELDERLY OR FRAIL PATIENTS WITH DIFFUSE LARGE CELL LYMPHOMA, COMPARING R-POLA-MINI-CHP AND R-MINI-CHOP

HemaSphere2023-08-0119 citations